Now I have all the content. Let me create a comprehensive, easy-to-understand study guide.
π Sedatives & Hypnotics β Medicinal Chemistry Made Easy
π§ First, Get the Big Picture
Sedative = Calms you down (smaller dose)
Hypnotic = Puts you to sleep (larger dose)
Same drug, different dose = different effect!
Memory trick: Think of a cinema (SED-ative = SEDentary, sitting calm; HYP-notic = HYPnotized to sleep)
π The Master Key: GABA & Chloride
Almost all sedative-hypnotics work by the same lock β the GABA-A receptor.
GABA-A Receptor = A door with 5 subunits
The door controls Clβ» (chloride) ions
More Clβ» inside β neuron becomes negative β SLOWS DOWN brain
| Drug Class | What they do to GABA-A |
|---|
| Benzodiazepines | β frequency of Clβ» channel opening |
| Barbiturates | β duration of Clβ» channel opening |
| Barbiturates (high dose) | Open channel WITHOUT GABA (dangerous!) |
Memory trick: "BZD = Frequency, Barb = Duration"
Think: Benzodiazepine β Beats (frequency of opening); Barbiturate β Big long open door (duration)
PART 1: BENZODIAZEPINES
ποΈ Structure β 3 Rings to Remember
Think of it as Ring A + Ring B + Ring C = Activity
[Ring A]
|
[Ring B] β The 7-membered diazepine ring (the "engine")
|
[Ring C]
Ring A Rules (easy way to remember: "7 is VIP, 6-8-9 Stay Away")
- Ring A must be aromatic β
- Position 7 = needs an electronegative group (Cl, NOβ, CFβ) β MORE electronegative = MORE potent
- Positions 6, 8, 9 = must be unsubstituted (leave them alone!)
Ring C Rules (remember: "Ortho is Gold, Para is Bad")
- A phenyl group at position 5 is needed
- Ortho/di-ortho substitution with electron-withdrawing groups = β activity
- Para substitution = β activity (kills it)
Ring B Rules (the diazepine ring β remember: "4,5 = Don't Touch, 3-OH = Long or Short")
- The 4,5-double bond must stay in place (shift it β lose activity)
- 3-OH present β drug is polar β short-acting (rapidly glucuronidated and excreted)
- No 3-OH β drug is nonpolar β long-acting (slowly hydroxylated in liver)
- The 2-carbonyl (C=O at position 2) is essential
- N1 nitrogen must be present; alkyl groups at N1 are tolerated
- Fusing a triazole or imidazole ring at positions 1,2 increases activity (e.g., alprazolam, triazolam)
β±οΈ Duration Classification (Easy Table)
| Duration | Half-life | Examples | Use |
|---|
| Long | >24 hrs | Diazepam, Nitrazepam, Flurazepam | Anxiety |
| Intermediate | 12β24 hrs | Alprazolam, Lorazepam, Clonazepam | Anxiety & Insomnia |
| Short | <12 hrs | Midazolam, Triazolam | Insomnia |
Memory trick: "For Anxiety = Long; For Insomnia = Short/Intermediate"
π Individual BZD Drug Facts
Diazepam
- Prototype BZD; metabolized β Nordazepam β Oxazepam (both active)
- Enzymes: CYP2C19 + CYP3A4
Oxazepam
- Active metabolite of BOTH diazepam AND chlordiazepoxide
- Prototype of 3-hydroxy BZDs (short-acting, rapidly glucuronidated β excreted)
Chlordiazepoxide
- Metabolized β Demoxepam β Nordazepam β Oxazepam
- Memory trick: "Chlor β Demo β Nord β Oxa" (like a relay race)
Clorazepate
- Prodrug β decarboxylated by stomach acid β Nordazepam
- Memory trick: "Clorazepate = CloRAzepate = RAw material (prodrug)"
Alprazolam
- Has a triazole ring fused (that's why it's potent)
- Intermediate acting, used for anxiety & panic attacks
- β οΈ Avoid in pregnancy (fetal abnormalities) and breastfeeding
Lorazepam
- High-potency, intermediate-acting
- Uses: anxiety, insomnia, acute seizures, aggressive patients, stimulant overdose
Zolpidem (Non-BZD BzRA)
- Not a true benzodiazepine but acts on BZD site
- Selective for Ξ±1 subunit β mainly hypnotic (not anxiolytic)
- Metabolized by CYP3A4 β Ξ±-hydroxylation β inactive metabolites β urine
- Short half-life; increases in elderly/liver disease
PART 2: BARBITURATES
ποΈ Core Structure: Barbituric acid = Pyrimidine with 3 oxygens at positions 2, 4, 6
Barbituric acid itself = NO activity!
Activity requires substituents at Position 5 (both H must be replaced by alkyl/aryl)
Why must both H at C5 be replaced?
If one H remains β tautomerizes to trihydroxypyrimidine (pKa ~4) β mostly ionized at body pH β cannot cross blood-brain barrier β no CNS effect
π SAR of Barbiturates β Summary Table
| Change | Effect |
|---|
| C5: both H replaced by alkyl/aryl | Activity begins |
| C5: total carbons 4β10 | Optimal activity |
| C5: branched chain | More potent, shorter duration |
| C5: unsaturated (double bond) | Short-acting (easily oxidized) |
| C5: halogen in alkyl chain | β potency |
| C5: polar groups (OH, COOH, NHβ) | β potency |
| C5: cyclic/aromatic > aliphatic | More potent |
| C5: short chains | Long-acting (resist oxidation) |
| C5: long chains | Short-acting (easily oxidized) |
| N substitution (methylation) | Faster onset, shorter duration |
| C2: O replaced by S (thiobarbiturate) | Much more lipophilic β ultra-short acting IV anesthetic |
| C2: O replaced by N | Activity abolished |
β‘ The Lipophilicity Rule (Most Important SAR Concept)
More lipophilic β Faster onset β Shorter duration
(because it distributes into fat and is metabolized quickly)
Less lipophilic β Slower onset β Longer duration
(stays in blood longer, excreted unchanged)
The S-trick: Replace O at C2 with S β lipophilicity explodes β Thiopental (IV anesthetic, ultra-short)
π Duration Classification
| Drug | Duration | Special Notes |
|---|
| Phenobarbital | Long (2β7 days!) | Anticonvulsant, neonatal seizures |
| Mephobarbital | Long | Demethylated β phenobarbital |
| Amobarbital | Intermediate | β |
| Butabarbital | Intermediate | β |
| Pentobarbital | Short | Branched chain |
| Secobarbital | Short | Unsaturated chain |
| Thiopental | Ultra-short | IV anesthetic (thio = S at C2) |
π Metabolism of Barbiturates
Polar barbiturates β excreted unchanged in urine
Nonpolar (lipophilic) barbiturates undergo:
- Oxidation at C5 β hydroxy/keto/carboxy derivatives
- Ring opening by hydrolysis
- N-dealkylation (e.g., mephobarbital β phenobarbital)
- Desulfurization (thiopental β pentobarbital)
PART 3: MISCELLANEOUS AGENTS
Glutethimide (Amide/Imide class)
- Structurally similar to phenobarbital
- Racemic mixture used
- Metabolized in liver (tΒ½ ~10 hrs) β glucuronide conjugate
- Enzyme inducer
Alcohols & Carbamate Derivatives
Potency rules for alcohols:
- CNS depression β up to 8 carbons, then β
- Branching β potency: tertiary β₯ secondary β₯ primary
- Why? Tertiary/secondary not oxidized to carboxylic acids β stay active longer
- Halogen in alkyl chain β β potency
- Carbamylation (making carbamate from alcohol) β β potency + more resistant to metabolism
Meprobamate
- Antianxiety + sedative-hypnotic + muscle relaxant
- Does NOT act on GABA-A (mechanism unclear)
- Effective against absence seizures; may worsen tonic-clonic seizures
Ethchlorvynol
- Quick onset, short duration (tΒ½ = 5.6 hrs)
- Induces hepatic microsomal enzymes
Aldehydes
Paraldehyde (1882)
- One of the oldest and safest hypnotics
- Limited use due to: unpleasant taste, pungent odor, mucous membrane irritation
Triclofos
- Prodrug β metabolized β trichloroethanol (active form)
π― Exam Memory Tricks (Quick Recall)
| Concept | Mnemonic |
|---|
| BZD β β frequency of Clβ» | BZD = Beats per minute |
| Barbiturate β β duration of Clβ» | Barbiturate = Bar stays open longer |
| BZD needs GABA to work; Barb doesn't (high dose) | "BZD is shy (needs GABA); Barb is bold (acts alone)" |
| 3-OH BZDs = short acting | "OH no, it's short!" |
| No 3-OH = long acting | "No OH, No rush β it lasts" |
| C2 OβS = thiobarbiturate = ultra-short IV | "Sulfur = Speed" |
| C5 branched = short acting, potent | "Branchy trees fall fast" |
| C5 long chain = short acting | "Long chain burns quick" |
| Position 7 of BZD Ring A = electronegative = active | "7 is the lucky electronegative number" |
| Clorazepate = prodrug activated by stomach acid | "Acid unlocks Clorazepate" |
πΊοΈ One-Page Summary Flowchart
SEDATIVES & HYPNOTICS
|
Work via GABA-A receptor (Clβ» channel)
|
_____|_____
| |
BZDs Barbiturates
| |
β Frequency β Duration
of opening of opening
| |
Need GABA High dose:
No GABA needed
This covers your entire PDF β GABA mechanism, BZD SAR, Barbiturate SAR, individual drug profiles, and miscellaneous agents β in a way built for exam recall. Focus especially on the SAR tables and the BZD vs. Barbiturate MOA comparison, as those are the most exam-heavy topics in medicinal chemistry.